Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Clinical trial NCT01111318 · COMPLETED

Trial details

NCT number: NCT01111318
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Healthy

Start date: 2010-07-01
Primary completion: 2010-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.